Medlab Clinical has been granted clinical investigational new drug (IND) status by the US Food and Drug Administration (FDA) for cancer-related pain treatment NanaBis.

Join the Cannabiz revolution

Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?

This article is included with our Premium subscription.

The move allows Medlab to initiate a Phase III trial in the US, joining the UK and Australia as approved Phase III trial jurisdictions.

Prior to launching Cannabiz, Martin was co-founder and CEO of Asia-Pac’s leading B2B media and marketing information brand Mumbrella, overseeing its sale to Diversified Communications in 2017. A journalist...